Cook eyes peripheral arteries in new stab at DES (drug-eluting stents) sector
This article was originally published in Clinica
Executive Summary
After failing in recent years to establish itself among the key sellers of drug-eluting stents (DES) for coronary artery disease, Cook is looking towards the peripheral artery market as a means of cashing in on the spoils promised by DES technology.